X4 Pharmaceuticals Inc.
XFOR | NASDAQ
$3.49
$0 (-0.14%)
Sep 22, 2026, 11:30 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 8.81M | 2.71M | 2.57M | 1.77M | 1.97M | 28.81M | 1.43M | 560K | 563K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.62M | 598K | 387K | 374K | 494K | 5.01M | 302K | 307K | 462K | 62K | 62K | 502K | 516K | 512K | 501K | 494K | 500K | 499K | 494K | 491K | 487K | 420K |
Gross Profit | 7.19M | 2.11M | 2.18M | 1.39M | 1.48M | 23.8M | 1.13M | 253K | 101K | -62K | -62K | -502K | -516K | -512K | -501K | -494K | -500K | -499K | -494K | -491K | -487K | -420K |
Operating Income | -16.39M | -20.31M | -23.7M | -27.51M | -26.23M | -9.44M | -35.72M | -34.5M | -33.9M | -37.29M | -25.2M | -27.21M | -25.81M | -29.3M | -25.58M | -20.15M | -20.57M | -21.78M | -19.3M | -19.12M | -19M | -17.94M |
Interest Income | 1.98M | 2.11M | 1.99M | 901K | 665K | 1.02M | 1.27M | 1.87M | 1.57M | 1.07M | 1.45M | 1.39M | 914K | 835K | 198K | 14K | 4K | 3K | 3K | 2K | 3K | 2K |
Pretax Income | -16.16M | -20.24M | -23.93M | -29.85M | -25.7M | 316K | -39.56M | -36.68M | 90.85M | -51.75M | -19.1M | -2.28M | -55.7M | -24.02M | -29.09M | -21.6M | -21.21M | -21.94M | -30.2M | -20.17M | -19.63M | -18.67M |
Net Income | -16.16M | -20.24M | -23.93M | -29.82M | -25.74M | 282K | -39.82M | -36.7M | 90.83M | -51.77M | -19.13M | -2.31M | -55.71M | -24.02M | -29.1M | -21.59M | -21.21M | -21.97M | -30.21M | -20.18M | -19.64M | -18.68M |
Selling & General & Admin | 8.5M | 6.97M | 7.38M | 11.59M | 9.53M | 15.02M | 15.15M | 15.66M | 13.28M | 17.44M | 9.93M | 8.13M | 10.2M | 7.24M | 6.56M | 6.04M | 6.75M | 7.66M | 7.14M | 5.93M | 5.8M | 5.83M |
Research & Development | 15.08M | 15.45M | 18.5M | 17.31M | 18.18M | 18.22M | 21.7M | 19.09M | 20.72M | 19.79M | 15.21M | 18.58M | 15.09M | 21.55M | 18.51M | 13.62M | 13.32M | 13.61M | 11.67M | 12.7M | 12.71M | 11.68M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 23.58M | 22.42M | 25.88M | 28.9M | 27.71M | 33.24M | 36.85M | 34.75M | 34M | 37.23M | 25.14M | 26.71M | 25.29M | 28.79M | 25.08M | 19.66M | 20.07M | 21.28M | 18.8M | 18.63M | 18.51M | 17.52M |
Interest Expense | 2.16M | 2.13M | 2.19M | 2.26M | 2.23M | 2.2M | 2.3M | 2.41M | 2.18M | 1.87M | 1.89M | 1.63M | 1.15M | 1.11M | 1.14M | 1.02M | 918K | 913K | 925K | 920K | 905K | 891K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 25.2M | 23.01M | 26.27M | 29.27M | 28.21M | 38.25M | 37.15M | 35.06M | 34.46M | 37.29M | 25.2M | 27.21M | 25.81M | 29.3M | 25.58M | 20.15M | 20.57M | 21.78M | 19.3M | 19.12M | 19M | 17.94M |
Income Tax Expense | 2K | n/a | n/a | -30K | 37K | 34K | 258K | 15K | 18K | 19K | 33K | 26K | 15K | 4K | 14K | -13K | 4K | 23K | 3K | 2K | 6K | 6K |
Shares Outstanding (Basic) | 126.34M | 126.29M | 110.56M | 43.27M | 7.41M | 6.84M | 6.76M | 6.7M | 6.68M | 6.67M | 6.63M | 6.57M | 5.62M | 4.87M | 3.36M | 2.77M | 1.18M | 1.12M | 967.03K | 886.97K | 884.23K | 691.7K |
Shares Outstanding (Diluted) | 126.34M | 126.29M | 110.56M | 43.27M | 7.41M | 6.87M | 6.76M | 6.7M | 6.69M | 6.67M | 6.63M | 6.57M | 5.62M | 4.87M | 3.36M | 2.77M | 1.18M | 1.12M | 967.03K | 886.97K | 884.23K | 691.7K |
EPS (Basic) | -0.13 | -0.16 | -0.22 | -0.69 | -3.47 | 0.04 | -6 | -5.48 | 13.60 | -7.77 | -2.89 | -0.35 | -9.91 | -4.94 | -8.66 | -7.89 | -17.96 | -21.54 | -37.14 | -22.75 | -22.21 | -38.91 |
EPS (Diluted) | -0.13 | -0.16 | -0.22 | -0.69 | -3.47 | 0.04 | -6 | -5.48 | 13.57 | -7.77 | -2.89 | -0.35 | -9.91 | -4.94 | -8.66 | -7.89 | -17.96 | -21.54 | -37.14 | -22.75 | -22.21 | -38.91 |
EBITDA | -12.77M | -17.87M | -21.52M | -27.37M | -23.1M | 3.01M | -36.99M | -33.99M | 93.22M | -49.81M | -17.15M | -143K | -54.03M | -22.4M | -27.45M | -20.09M | -19.79M | -20.53M | -28.79M | -18.76M | -18.24M | -17.52M |
EBIT | -13.99M | -18.11M | -21.74M | -27.59M | -23.47M | 2.52M | -37.26M | -34.27M | 93.03M | -49.87M | -17.21M | -645K | -54.55M | -22.91M | -27.95M | -20.58M | -20.29M | -21.03M | -29.28M | -19.25M | -18.73M | -17.94M |
Depreciation & Amortization | 1.22M | 236K | 223K | 223K | 368K | 489K | 273K | 280K | 194K | 62K | 62K | 502K | 516K | 512K | 501K | 494K | 500K | 499K | 494K | 491K | 487K | 420K |
Add to Watchlist
Select watchlists to add or remove XFOR